John SchardtSenior Scientist at AstraZenecaSpeaker
Agenda Sessions
Design Meets Biology – Engineering Immune Engagers with Potentially Improved Therapeutic Index
, 10:00amView Session
Design Meets Biology – Engineering Immune Engagers with Potentially Improved Therapeutic Index